Miller CM - Search Results

1

The International Liver Transplantation Society Living Donor Liver Transplant Recipient Guideline.

Miller CM, Quintini C, Dhawan A, Durand F, Heimbach JK, Kim-Schluger HL, Kyrana E, Lee SG, Lerut J, Lo CM, Pomfret EA. Miller CM, et al. Transplantation. 2017 May;101(5):938-944. doi: 10.1097/TP.0000000000001571. Transplantation. 2017. PMID: 28437386 Free PMC article.

2

The splenic artery as the inflow in arterial revascularization of the liver graft in clinical liver transplantation.

Katz E, Fukuzawa K, Schwartz M, Mor E, Miller C. Katz E, et al. Transplantation. 1992 Jun;53(6):1373-4. Transplantation. 1992. PMID: 1376505 No abstract available.

3

Evidence that the systematic analysis of bile cytology permits monitoring of hepatic allograft rejection.

Roberti I, Lieberman KV, Manzarbeitia C, Schwartz M, Reisman L, Miller C. Roberti I, et al. Transplantation. 1992 Sep;54(3):471-4. doi: 10.1097/00007890-199209000-00017. Transplantation. 1992. PMID: 1384182

4

Orthotopic liver transplantation for secondary sclerosing cholangitis associated with hepatic artery embolization.

Manzarbeitia C, Schwartz ME, Berman HL, Miller CM. Manzarbeitia C, et al. Among authors: miller cm. Transplant Proc. 1992 Apr;24(2):745-7. Transplant Proc. 1992. PMID: 1566504 No abstract available.

5

Accessory right hepatic duct stricture following liver transplantation.

Manzarbeitia C, Schwartz ME, Train JS, Miller CM. Manzarbeitia C, et al. Among authors: miller cm. Transplantation. 1991 Sep;52(3):556-8. Transplantation. 1991. PMID: 1897031 No abstract available.

6

Initial flush solution for donor liver procurement: lactated Ringers' or UW solution? A randomized, prospective trial.

Schwartz ME, Nishizaki T, Thung SN, Manzarbeitia C, Maharajh A, Gordon R, Miller CM. Schwartz ME, et al. Among authors: miller cm. Transplant Proc. 1991 Feb;23(1 Pt 2):1554-6. Transplant Proc. 1991. PMID: 1989287 Clinical Trial. No abstract available.

7

Reversal of gastrointestinal toxicity associated with long-term FK506 immunosuppression by conversion to cyclosporine in liver transplant recipients.

Mor E, Schwersenz A, Sheiner PA, Emre S, Schwartz ME, Miller CM. Mor E, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1130-2. Transplantation. 1994. PMID: 7513098 No abstract available.

8

Acute renal failure associated with the use of ibuprofen in two liver transplant recipients on FK506.

Sheiner PA, Mor E, Chodoff L, Glabman S, Emre S, Schwartz ME, Miller CM. Sheiner PA, et al. Among authors: miller cm. Transplantation. 1994 Apr 15;57(7):1132-3. Transplantation. 1994. PMID: 7513099 No abstract available.

9

Serum lipid changes in liver transplant recipients in a prospective trial of cyclosporine versus FK506.

Jindal RM, Popescu I, Emre S, Schwartz ME, Boccagni P, Meneses P, Mor E, Sheiner P, Miller CM. Jindal RM, et al. Among authors: miller cm. Transplantation. 1994 May 15;57(9):1395-8. doi: 10.1097/00007890-199405150-00020. Transplantation. 1994. PMID: 7514317 Clinical Trial. No abstract available.

10

Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.

Jindal RM, Popescu I, Schwartz ME, Emre S, Boccagni P, Miller CM. Jindal RM, et al. Among authors: miller cm. Transplantation. 1994 Aug 15;58(3):370-2. Transplantation. 1994. PMID: 7519799 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

546 results

Search Page

Filters